Alertas sanitarias de productos médicos subestándares, falsificados y no registrados al inicio de la pandemia de COVID-19 en las Américas / Health alerts for substandard, falsified, and unregistered medical products at the onset of the COVID-19 pandemic in the Americas / Alertas de saúde para produtos médicos abaixo do padrão, falsificados e não registrados no início da pandemia de COVID-19 nas Américas

RESUMEN Objetivo. Identificar y analizar los incidentes de productos médicos subestándares, falsificados, no registrados y robados al inicio de la pandemia de COVID-19. Métodos. Búsqueda detallada en los sitios web de las autoridades reguladoras de las Américas. Identificación de los incidentes de medicamentos y dispositivos médicos (incluidos los de diagnóstico in vitro) subestándares falsificados, no registrados y robados. Se determinaron los tipos de productos, las etapas de la cadena de suministro en las que se detectaron y las medidas tomadas por las autoridades. Resultados. Se identificaron 1 273 incidentes en 15 países (1 087 productos subestándares, 44 falsificados, 123 no registrados y 19 robados). La mayor cantidad de incidentes corresponden a dispositivos médicos, desinfectantes y antisépticos. El punto en la cadena de suministro con mayor frecuencia de informes fue la adquisición a través de internet. Las medidas tomadas por las autoridades reguladoras corresponden en su mayoría a: alerta, prohibición de uso, prohibición de publicidad y fabricación, retiro del mercado y seguimiento de eventos adversos. Conclusiones. Se evidenció un número destacable de incidentes de productos médicos subestándares, falsificados, no registrados y robados al inicio de la pandemia por COVID-19. La escasez de insumos, la flexibilización en los requisitos regulatorios y el aumento de la demanda son factores que pueden favorecer el incremento del número de incidentes. Las autoridades reguladoras nacionales de referencia presentaron mayores frecuencias de detección de incidentes y de aplicación de medidas sanitarias. Se observó que se debe abordar el canal de venta por internet con alguna estrategia reguladora para garantizar la distribución segura de productos médicos.

ABSTRACT Objective. Identify and analyze incidents of substandard, falsified, unregistered, and stolen medical products at the onset of the COVID-19 pandemic. Methods. Detailed search of the websites of regulatory authorities in the Americas. Identification of incidents of substandard, falsified, unregistered, and stolen medicines and medical devices (including in vitro diagnostics). The types of products were determined, as were the stages in the supply chain where they were detected, and the actions taken by authorities. Results. A total of 1 273 incidents were identified in 15 countries (1 087 substandard, 44 falsified, 123 unregistered, and 19 stolen products). The largest number of incidents involved medical devices, disinfectants, and antiseptics. The most frequently reported point in the supply chain was online purchasing. The principal measures taken by the regulatory authorities were: alerts, prohibition of use, prohibition of advertising and manufacture, recall, and monitoring of adverse events. Conclusions. A substantial number of incidents involving substandard, falsified, unregistered, and stolen medical products at the onset of the COVID-19 pandemic were identified. Shortages of supplies, easing of regulatory requirements, and increased demand are factors that may have led to an increase in the number of incidents. The national regulatory authorities of reference reported more frequent detection of incidents and more frequent application of health measures. A regulatory strategy is needed in order to address online sales and ensure the safe distribution of medical products.

RESUMO Objetivo. Identificar e analisar incidentes de produtos médicos abaixo do padrão, falsificados, não registrados e roubados no início da pandemia de COVID-19. Métodos. Foi realizada uma busca detalhada nos sites das autoridades reguladoras das Américas. Foram identificados incidentes envolvendo medicamentos e dispositivos médicos (incluindo para diagnóstico in vitro) abaixo do padrão, falsificados, não registrados e roubados. Foram determinados os tipos de produtos, os estágios da cadeia de abastecimento em que foram detectados e as medidas tomadas pelas autoridades. Resultados. Foram identificados 1 273 incidentes em 15 países (1 087 produtos abaixo do padrão, 44 falsificados, 123 não registrados e 19 roubados). O maior número de incidentes estava relacionado a dispositivos médicos, desinfetantes e antissépticos. O ponto na cadeia de abastecimento com a maior frequência de relatos foi a de aquisição pela internet. As medidas tomadas pelas autoridades reguladoras foram principalmente alertas, proibições de uso, proibições de publicidade e fabricação, recolhimento de produtos do mercado e monitoramento de eventos adversos. Conclusões. Houve um número significativo de incidentes envolvendo produtos médicos abaixo do padrão falsificados, não registrados e roubados no início da pandemia de COVID-19. A escassez de insumos, a flexibilização das exigências regulatórias e o aumento da demanda são fatores que podem levar a um maior número de incidentes. As autoridades reguladoras nacionais de referência informaram um aumento na frequência de detecção de incidentes e implementação de medidas sanitárias. O canal de vendas pela internet precisa ser abordado com alguma estratégia regulatória para garantir a distribuição segura de produtos médicos.

Brazilian guidelines for the pharmacological treatment of the pulmonary symptoms of cystic fibrosis. Official document of the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT, Brazilian Thoracic Association) / Diretrizes brasileiras para o tratamento farmacológico pulmonar na fibrose cística. Documento oficial da Sociedade Brasileira de Pneumologia e Tisiologia

ABSTRACT Cystic fibrosis (CF) is a genetic disease that results in dysfunction of the CF transmembrane conductance regulator (CFTR) protein, which is a chloride and bicarbonate channel expressed in the apical portion of epithelial cells of various organs. Dysfunction of that protein results in diverse clinical manifestations, primarily involving the respiratory and gastrointestinal systems, impairing quality of life and reducing life expectancy. Although CF is still an incurable pathology, the therapeutic and prognostic perspectives are now totally different and much more favorable. The purpose of these guidelines is to define evidence-based recommendations regarding the use of pharmacological agents in the treatment of the pulmonary symptoms of CF in Brazil. Questions in the Patients of interest, Intervention to be studied, Comparison of interventions, and Outcome of interest (PICO) format were employed to address aspects related to the use of modulators of this protein (ivacaftor, lumacaftor+ivacaftor, and tezacaftor+ivacaftor), use of dornase alfa, eradication therapy and chronic suppression of Pseudomonas aeruginosa, and eradication of methicillin-resistant Staphylococcus aureus and Burkholderia cepacia complex. To formulate the PICO questions, a group of Brazilian specialists was assembled and a systematic review was carried out on the themes, with meta-analysis when applicable. The results obtained were analyzed in terms of the strength of the evidence compiled, the recommendations being devised by employing the GRADE approach. We believe that these guidelines represent a major advance to be incorporated into the approach to patients with CF, mainly aiming to favor the management of the disease, and could become an auxiliary tool in the definition of public policies related to CF.

RESUMO A fibrose cística (FC) é uma doença genética que resulta em disfunção da proteína reguladora de condutância transmembrana da FC (CFTR), que é um canal de cloro e bicarbonato expresso na porção apical de células epiteliais de diversos órgãos. A disfunção dessa proteína resulta em manifestações clínicas diversas, envolvendo primariamente os sistemas respiratório e gastrointestinal com redução da qualidade e expectativa de vida. A FC ainda é uma patologia incurável, porém o horizonte terapêutico e prognóstico é hoje totalmente distinto e muito mais favorável. O objetivo destas diretrizes foi definir recomendações brasileiras baseadas em evidências em relação ao emprego de agentes farmacológicos no tratamento pulmonar da FC. As perguntas PICO (acrônimo baseado em perguntas referentes aos Pacientes de interesse, Intervenção a ser estudada, Comparação da intervenção e Outcome [desfecho] de interesse) abordaram aspectos relativos ao uso de moduladores de CFTR (ivacaftor, lumacaftor + ivacaftor e tezacaftor + ivacaftor), uso de dornase alfa, terapia de erradicação e supressão crônica de Pseudomonas aeruginosa, e erradicação de Staphylococcus aureus resistente a meticilina e do complexo Burkholderia cepacia. Para a formulação das perguntas, um grupo de especialistas brasileiros foi reunido e realizou-se uma revisão sistemática sobre os temas, com meta-análise quando aplicável. Os resultados encontrados foram analisados quanto à força das evidências compiladas, sendo concebidas recomendações seguindo a metodologia GRADE. Os autores acreditam que o presente documento represente um importante avanço a ser incorporado na abordagem de pacientes com FC, objetivando principalmente favorecer seu manejo, podendo se tornar uma ferramenta auxiliar na definição de políticas públicas relacionadas à FC.

Research progress on cognitive impairment and intervention in patients with depression / 中华行为医学与脑科学杂志

Depression is one of the most common mental disorders, which can be accompanied by cognitive symptoms in addition to core symptoms.With the improvement of the awareness of the disease, people pay more attention to the cognitive symptoms of depression. The cognitive impairment of patients not only appears in the onset of the disease, but also persists during the remission of the disease, which has a negative impact on the patients’ social function. Some cognitive assessment tools such as cognitive tests, event-related potential(ERP) and eye movement tracking technology have been used to assess cognitive impairment in patients with depression, which show that there are multidimensional cognitive impairments. Some therapeutic methods such as exercise therapy, repetitive transcranial magnetic stimulation(rTMS) and drug therapy have shown the potential to improve the cognitive function of patients with depression. This article reviews related researches in recent years to explore the cognitive impairment and therapeutic methods of patients with depression.

Current status and new progress of drug therapy for premature ejaculation / 现代泌尿外科杂志

Premature ejaculation (PE) is the most common male sexual dysfunction with a high incidence, which seriously affects the relationship between a husband and wife and family harmony. Drug therapy is a first-line treatment for PE patients with premature ejaculation, and has achieved good efficacy, but the clinically available drugs are single and the abandonment rate is high. Coupled with the ineffective treatment of some patients, new drug research and development is imminent. This paper systematically reviews the current status of drug treatment for premature ejaculation, focusing on the research and development of new drugs and research progress in order to provide a reference for clinicians.

LDHA inhibitor combined with targeted drugs synergistically inhibit the proliferation of fumarate hydratase-deficient renal cell carcinoma cells / 现代泌尿外科杂志

【Objective】 To explore the therapeutic effects of lactate dehydrogenase A (LDHA) inhibitor and targeted drugs on fumarate-hydratase-deficient renal cell carcinoma (FH-d RCC). 【Methods】 RNA-sequencing was used to detect the mRNA expression in FH-d RCC tissues, which was further validated with real-time fluorescence quantitative PCR and immunohistochemistry. Human-derived FH-d RCC cell line UOK262 and murine-derived FH-d RCC cell line FH1-/-CL19 (CL19) were treated with LDHA inhibitor [(R)-GNE-140] and listed kidney cancer targeted drugs (Axitinib, Cabozantinib, Sunitinib, Sorafenib, Pazopanib, Everolimus) respectively, and then treated with LHDA inhibitor in combination with the targeted drugs to observe the alteration of cell proliferation. The combination index (CI) of different dose groups of the combination drugs were analyzed with CompuSyn software to determine the optimal combination regimen. 【Results】 LDHA inhibitor and targeted drugs, including Cabozantinib, Sorafenib and Sunitinib, had a significant inhibitory effect on the proliferation of FH-d RCC cells, and the combination of Cabozantinib and Sorafenib or Pazopanib had a significant anti-tumor effect. 【Conclusion】 LDHA inhibitor combined with targeted drugs can significantly inhibit the growth of FH-d RCC cells, indicating that LDHA may be a potential therapeutic target of FH-d RCC.

Preliminary results of anti-vascular endothelial growth factor treatment for macular edema secondary to branch retinal vein occlusion in Lhasa Tibet / 中华眼底病杂志

Objective:To observe and evaluate the safety and efficacy of anti-vascular endothelial growth factor (VEGF) in the treatment of eyes with macular edema (ME) secondary to branch retinal vein occlusion (BRVO) in Lhasa, Tibet.Methods:A retrospective case series. From September 2018 to January 2022, a total of 41 patients (41 eyes) with BRVO-ME, who were diagnosed in Department of Ophthalmology of Tibet Autonomous Region People’s Hospital, were included in this study. There were 21 eyes in 21 males and 20 eyes in 20 females. The median age was 53 (31,75) years. There were 24 patients with hypertension (58.8%, 24/41). Best corrected visual acuity (BCVA), ocular pressure, fundus color photography and optical coherence tomography (OCT) were performed in all eyes. The BCVA was performed using the international standard logarithmic visual acuity chart, which was converted into logarithm of the minimum angle of resolution (logMAR) BCVA for record. The foveal macular thickness (CMT) was measured by OCT. All eyes were treated with intravitreous injection of anti-VEGF drugs, once a month, among which 23 eyes (56.1%, 23/41) received intravitreous injection of ranibizumab (IVR), and 18 eyes (43.9%, 18/41) received intravitreous injection of conbercept (IVC), and were grouped accordingly. There was no significant difference in age ( Z=-0.447), gender composition ( Z=-0.485), logMAR BCVA ( t=-1.591), intraocular pressure ( t=-0.167) and CMT ( t=-1.290) between two groups ( P>0.05). During the follow-up, the same devices and methods were used at baseline to perform relevant examinations, and the changes of BCVA, intraocular pressure, CMT and new cardiovascular and cerebrovascular events were compared between baseline and the last follow-up. logMAR BCVA, intraocular pressure and CMT were compared between baseline and last follow-up using Student t test. The comparison of injection times and follow-up time between IVR group and IVC group was conducted by Mann-Whitney U test. Results:At baseline, logMAR BCVA, intraocular pressure, and CMT were 0.852±0.431, (12.5±2.5) mm Hg (1 mm Hg= 0.133 kPa), and (578.1±191.1) μm, respectively. At the last follow-up, the number of anti-VEGF drug treatments was (2.7±1.2) times; logMAR BCVA and CMT were 0.488±0.366 and (207.4±108.7) μm, respectively, with CMT > 250 μm in 14 eyes (34.1%, 14/41). Compared with baseline, BCVA ( t=4.129) and CMT ( t=-0.713) were significantly improved, with statistical significance ( P<0.001). The injection times of IVR group and IVC group were (2.6±0.9) and (3.0±1.5) times, respectively. There were no significant differences in the number of injection times ( t=-1.275), logMAR BCVA ( t=-0.492), intraocular pressure ( t=0.351) and CMT ( t=-1.783) between the two groups ( P>0.05). No new hypertension, cardiovascular and cerebrovascular events occurred in all patients during follow-up. At the last follow-up, there were no eye complications related to treatment modalities and drugs. Conclusion:Short-term anti-VEGF treatment can improve the visual acuity of BRVO secondary ME patients and alleviate ME in Lhasa, Tibet. The safety and efficacy of ranibizumab and conbercept were similar.

Avaliação in silico da afinidade de drogas ao receptor TRPA1 como preditor para o manejo farmacológico da sensibilidade provocada pelo clareamento dentário / In silico assessment of drug affinity to the TRPA1 receptor as a predictor for the pharmacological management of sensitivity caused by tooth whitening

Introdução: Reduzir a sensibilidade do clareamento dental em consultório representa um desafio para os profissionais. Pesquisadores associaram o bloqueio do receptor de dor TRPA1 com a redução da sensibilidade ao clareamento. No entanto, a afinidade química dos analgésicos/anti-inflamatórios para o TRPA1 ainda precisa ser averiguada. Objetivo: Realizar uma triagem virtual de múltiplos medicamentos (analgésicos e antiinflamatórios) para verificar a afinidade química pelo receptor TRPA1. Metodologia: A estrutura cristalina das proteínas do receptor TRPA1 foi recuperada do Protein Data Bank. Os códigos SMILES dos ligantes foram extraídos do PubChem. A energia de ligação do complexo foi obtida em ∆G - kcal/mol pelo AutoDock Vina© e replicada nos servidores SwissDock©, Dockthor© e CbDock©. LigPlus© confirmou os sítios de ligação. Resultados: Apesar dos antagonistas dos receptores analisados apresentarem alta afinidade, codeína e dexametasona apresentaram regularidade em todos os servidores, mesmo apresentando valores de energia de ligação de -7,9 kcal/mol para codeína e -8,1 kcal/mol para dexametasona. Conclusão: A codeína e a dexametasona podem ser drogas potenciais para controlar a sensibilidade ao clareamento dental caso atinjam o receptor TRPA1 da polpa dentária (AU).

Introduction: Reducing in-office tooth bleaching sensitivity represents a challenge for professionals. Researchers have associated the block of the pain receptor TRPA1 with reducing bleaching sensitivity. However, the chemical affinity of analgesic/antiinflammatory drugs to the TRPA1 needs to be verified. Objective: To perform a virtual screening of multiple drugs (analgesic and anti-inflammatory drugs) to verify chemical affinity for the TRPA1 receptor. Methodology: The crystal structure of the TRPA1 receptor proteins was retrieved from the Protein Data Bank. The SMILES codes of the ligands were extracted from PubChem. The binding energy of the complex was obtained in ∆G - kcal/mol by AutoDock Vina© and replicated in the webservers SwissDock©, Dockthor©, and CbDock©. LigPlus© confirmed the binding sites. Results: Although the receptor antagonists analyzed showed high affinity, codeine and dexamethasone showed regularity among all servers, even showing binding energy values of -7.9 kcal/mol for codeine and -8.1 kcal/mol for dexamethasone. Conclusion: Codeine and dexamethasone may be potential drugs to manage tooth bleaching sensitivity if they reach the dental pulp TRPA1 receptor (AU).

Cuidados paliativos na assistência domiciliar: Segurança do paciente no uso de medicamentos / Cuidado paliativo en el cuidado doméstico: Seguridad del paciente en el uso de medicamentos / Palliative care in home care: Patient safety in use of medicines

Objetivo: Investigar os fatores associados à segurança dos pacientes em cuidados paliativos domiciliares quanto ao uso medicamentos. Método: Trata-se de um estudo exploratório, descritivo, com abordagem quantitativa, realizado com cuidadores familiares de indivíduos com doenças crônicas acompanhados na Unidade de Cuidados Paliativos e Tratamento da dor, em um hospital de referência em Recife - PE. A coleta de dados ocorreu por meio de entrevista, utilizando um roteiro semiestruturado. Os dados foram organizados em planilha construída no programa Microsoft Excel e analisados por meio de estatística descritiva. Resultados: Verificou-se que a maioria dos cuidadores mantém o armazenamento dos medicamentos longe do calor e da incidência do sol, além da verificação rotineira da validade antes da administração. Entretanto, 43,75% dos cuidadores não possuem o hábito de ler a bula e 50% referem, em algum momento, já ter trocado a medicação e/ou horário do remédio do paciente. Conclusões: Foi evidenciado a atenção no armazenamento dos medicamentos, porém há necessidade da implementação de estratégias para garantir a segurança na administração dos medicamentos no domicilio.(AU)

Objective: To investigate the factors associated with patient safety in home palliative care regarding medication use. Method: This is an exploratory, descriptive study with a quantitative approach, carried out with family caregivers of individuals with chronic diseases followed up at the Palliative Care and Pain Treatment Unit (UCPD), in a referral hospital in Recife - PE. Data collection took place through interviews, using a semi-structured script. Data were organized in a spreadsheet built in Microsoft Excel and analyzed using descriptive statistics. Results: It was found that most caregivers keep medication storage away from heat and sunlight, in addition to routinely checking the validity before administration. However, 43.75% of caregivers do not have the habit of reading the leaflet and 50% report, at some point, having already changed the patient's medication and/or medication schedule. Conclusions: Attention to the storage of medicines was evidenced, but there is a need to implement strategies to ensure safety in the administration of medicines at home.(AU)

Objetivo: Investigar los factores asociados a la seguridad del paciente en cuidados paliativos domiciliarios en cuanto al uso de medicamentos. Método: Se trata de un estudio exploratorio, descriptivo, con abordaje cuantitativo, realizado con cuidadores familiares de personas con enfermedades crónicas acompañadas en la Unidad de Cuidados Paliativos y Tratamiento del Dolor (UCPD), en un hospital de referencia de Recife - PE. La recolección de datos ocurrió a través de entrevistas, utilizando un guión semiestructurado. Los datos se organizaron en una hoja de cálculo construida en Microsoft Excel y se analizaron mediante estadística descriptiva. Resultados: Se constató que la mayoría de los cuidadores mantienen el almacenamiento de medicamentos alejado del calor y la luz solar, además de verificar rutinariamente la validez antes de la administración. Sin embargo, el 43,75% de los cuidadores no tiene el hábito de leer el prospecto y el 50% refiere, en algún momento, haber cambiado ya la medicación y/o el horario de medicación del paciente. Conclusiones: Se evidenció atención al almacenamiento de medicamentos, pero existe la necesidad de implementar estrategias para garantizar la seguridad en la administración de medicamentos en el domicilio.(AU)

Perfil antibiótico de estreptococos del grupo viridans aislados de cavidad oral en individuos con uso prolongado de antibióticos / Antibiotic profile of viridans streptococci group isolated of oral cavity from patients with prolonged use of antibiotics

RESUMEN Los estreptococos del grupo viridans (EGV) son un grupo heterogéneo de bacterias saprófitas anaerobias facultativas que forman parte de la flora normal de cavidad oral. El incremento de la resistencia antibiótica de este grupo de bacterias cobra importancia en pacientes hospitalizados con terapia antibiótica prolongada, en los cuales estos microorganismos pueden ser sustituidos por bacterias multirresistentes. Objetivos: Determinar el porcentaje de cepas de EGV aisladas de cavidad oral resistentes a los antibióticos utilizados en el tratamiento de diversas patologías infecciosas hospitalarias. Material y Métodos: Estudio observacional descriptivo en el que se incluyeron 60 pacientes hospitalizados con historia de terapia antibiótica por más de 3 semanas. Las muestras se procesaron siguiendo protocolos estandarizados de recolección, aislamiento e identificación para EGV de cavidad oral y un protocolo de pruebas de sensibilidad antibiótica. Los resultados se muestran en tablas y gráficas de frecuencia. Resultados: La principal indicación para terapia antibiótica intrahospitalaria fue infección orofacial: 28,33%. La penicilina fue el antibiótico más utilizado ya sea en terapia única, combinada o múltiple en todos los pacientes. Se aislaron en total 108 cepas de EGV, con un promedio de 1,8 cepas por paciente. La especie predominantemente identificada fue S. mutans. El 96,3% de las cepas de EGV fue sensible a todos los antibióticos incluidos en el panel. Conclusiones: El uso de distintas combinaciones y modalidades de terapia antibiótica no tiene efecto en la susceptibilidad de EGV aislados de cavidad oral en pacientes hospitalizados, independiente de la duración del tratamiento.

ABSTRACT Viridans group streptococci (VGS) are a heterogeneous group of saprophytic facultative anaerobic bacteria that are part of the normal flora of the oral cavity. The increased resistance to multiple antibiotics in this group of bacteria becomes important in prolonged antibiotic therapies inpatient where these common microorganisms are replaced by multi-resistant bacteria. Objectives: To determine the percentage of VGS strains isolated from oral cavity resistant to antibiotics used in hospital infectious diseases. Material and methods: This is a descriptive cross-sectional study that included 60 hospitalized patients with a history of antibiotic therapy for more than 3 weeks. The samples were processed following standardized protocols for collection, isolation and identification of oral cavity VGS and a protocol of antibiotic susceptibility testing. The results are shown in tables and graphics of absolute and relative frequencies. Results: The main indication for antibiotic therapy was orofacial infection with a 28.33%. Penicillin was the antibiotic further used either in single, combined or multiple therapies in all patients. A total of 108 samples (1.8 per patient swabs) were collected. The predominantly identified specie was Streptococcus mutans. The 96.3% of all VGS strains were sensitive to all antibiotics included in the panel. Conclusion: Using different combinations and types of antibiotic therapy inpatient has no effect on the susceptibility of VGS isolated from oral cavity separate from treatment.

Demographic characteristics and treatment of patients with skeletal fluorosis in Inner Mongolia Autonomous Region in 2020 / 中华地方病学杂志

Objective:To understand the demographic characteristics and treatment intention, treatment status and therapeutic effect of patients with skeletal fluorosis in Inner Mongolia Autonomous Region (reffered to as Inner Mongolia) in order to provide a basis for next step treatment program.Methods:From March to June 2020, a face-to-face questionnaire survey was conducted among 3 570 patients with skeletal fluorosis in 11 leagues (cities) of Inner Mongolia to understand their basic information, treatment intention, treatment status and therapeutic effect. Patients with skeletal fluorosis of different demographic characteristics were compared with each other in their treatment intention and treatment status, and the therapeutic effects of different drugs were compared by χ 2 test. Results:A total of 3570 patients with skeletal fluorosis were investigated. There were slightly more women than men with skeletal fluorosis (1.29 ∶ 1.00, 2 014/1 556). The ages were mainly from 40 to 79 years old (95.4%, 3 406/3 570). Mongols patients accounted for 36.0% (1 285/3 570). Patients with low education (primary school and below) accounted for 82.2% (2 935/3 570). Eighty-five per cent (3 035/3 570) of the patients had drug treatment intention and 37.1% (1 325/3 570) of the patients had drug treatment. Thirty-seven point five per cent (1 338/3 570) of the patients had surgery intention and surgery was performed in 0.2% (8/3 570) of the patients. Combination therapy (98.5%, 194/197) and chondroprotective agents alone (98.3%, 173/176) were more effective than anti-inflammatory and analgesic agents alone (84.2%, 48/57) in the treatment of skeletal fluorosis ( P < 0.05). Surgery was effective (8/8). Conclusions:Most of the patients with skeletal fluorosis are middle-aged and elderly, and the patients with skeletal fluorosis in Mongols account for a certain proportion. At present, all the patients with skeletal fluorosis who have the will to be treated have not been effectively treated, and the means of treatment is relatively single. It should be advocated to carry out various forms of treatment of skeletal fluorosis, so that patients could relieve symptoms, reduce pain and improve their quality of life.

Willingness of Kashin-Beck disease patients to accept drug treatment and its influencing factors in Shaanxi Province from 2018 to 2020 / 中华地方病学杂志

Objective:To investigate the willingness of patients with Kashin-Beck disease (KBD) to accept drug treatment and its influencing factors in Shaanxi Province, in order to provide a reference for promoting the standardized management of KBD patients.Methods:The general information of KBD patients in Shaanxi Provincial Endemic Disease Prevention and Control Information System from January 2018 to December 2020 was collected, including gender, age (< 50, 50 - 79, ≥80 years old), ethnicity (Han nationality, others), education level (primary school and below, junior high school, senior high school and above), occupation (farmer, others), region (northern Shaanxi, central Shaanxi, southern Shaanxi), disease severity (gradeⅠ,Ⅱ,Ⅲ), etc. A face-to-face questionnaire survey was conducted to investigate the willingness of KBD patients to accept drug treatment, mainly including the willingness of patients to accept drug treatment, management services (whether the poor population, participation in medical insurance, disability assessment) and the implementation of comprehensive prevention and control measures (type of drinking water, types and sources of staple food, relocation from other places and returning farmland to forests). Multivariate logistic regression analysis was used to analyze the influencing factors of KBD patients' willingness to accept drug treatment.Results:A total of 58 501 KBD patients were included, including 51.60% (30 185/58 501) males and 48.40% (28 316/58 501) females; the median age was 64 years old; the ethnicity was mainly Han nationality, accounting for 99.87% (58 427/58 501); the education level of primary school and below accounted for 81.76% (47 831/58 501); the occupation was mainly farmers, accounting for 99.24% (58 059/58 501); mainly distributed in central Shaanxi [81.40% (47 619/58 501)]; patients with gradeⅠaccounted for 63.68% (37 254/58 501). Totally 89.02% (52 078/58 501) of KBD patients were willing to accept drug treatment. By multivariate logistic regression analysis, gender, age, education level, disease severity, region, medical insurance, disability assessment, type of drinking water, type of staple food, relocation from other places and returning farmland to forests were the influencing factors of KBD patients' willingness to accept drug treatment ( P < 0.05). Conclusions:KBD patients in Shaanxi Province have a high willingness to accept drug treatment. In the future, the standardized management of KBD patients should take into account the factors such as age, education level, disease severity and region, and implement precise drug treatment.

Discourses of health professionals on latent tuberculosis infection and the use of isoniazid / Discursos de profesionales de la salud sobre infección tuberculosis latente y uso de isoniazida / Discursos de profissionais de saúde sobre infecção latente por tuberculose e uso de isoniazida

ABSTRACT Objective to understand the collective thinking and action of health workers in relation to Latent Tuberculosis Infection and its treatment with Isoniazid. Method qualitative study with 22 health professionals from four cities in Brazil and the Federal District. Data collection occurred through a semi-structured group interview in March 2019, with an average duration of one hour and thirty minutes. Content analysis was performed using the Collective Subject Discourse technique. Results the professionals' discourses revealed uncertainties related to the prevention and treatment of Latent Tuberculosis Infection, the "fear of error" and inadequate forms of use of Isoniazid 300 mg, the power of the decision on the treatment of Latent Tuberculosis Infection, the difficulties of integration between services and the organization of care flows. Conclusion although the emphasis in the professionals' discourse considers objective aspects in the management of Latent Tuberculosis Infection, subjective manifestations related to the need to address the fears that affect the decision about treatment and possible medication errors were identified, among others, and to think about this process in a collaborative way, which considers autonomy in acting, both of professionals and of the person with Latent Tuberculosis Infection.

RESUMEN Objetivo comprender el pensamiento y la acción colectiva de los trabajadores de la salud en relación con la Infección Latente de Tuberculosis y el uso de Isoniazida en el enfrentamiento de la enfermedad. Método estudio cualitativo con 22 profesionales de la salud de cuatro ciudades de Brasil y del Distrito Federal. La recolección de datos ocurrió a través de una entrevista colectiva semiestructurada, en marzo de 2019, con una duración promedio de una hora y treinta minutos. El análisis de contenido se realizó mediante la técnica del Discurso del Sujeto Colectivo. Resultados los discursos de los profesionales revelaron incertidumbres relacionadas con la prevención y el tratamiento de la Infección Tuberculosa Latente, el "miedo a equivocarse" y las formas inadecuadas de uso de Isoniazida 300 mg, el poder de decisión sobre el tratamiento de la Infección Tuberculosa Latente, las dificultades para la integración de servicios y la organización de los flujos de atención. Conclusión aunque el énfasis en el discurso de los profesionales considera aspectos objetivos en el manejo de la Infección Tuberculosa Latente, se identificaron manifestaciones subjetivas relacionadas con la necesidad de abordar los miedos que afectan la decisión sobre el tratamiento y posibles errores de medicación, entre otros, y pensar sobre este proceso de forma colaborativa, que considera la autonomía de actuación, tanto de los profesionales como de la persona con Infección Tuberculosa Latente.

RESUMO Objetivo compreender o pensar e o agir coletivo de trabalhadores da saúde em relação à Infecção Latente por Tuberculose e ao uso da Isoniazida no enfrentamento da doença. Método estudo qualitativo com 22 profissionais de saúde de quatro cidades do Brasil e do Distrito Federal. A coleta de dados ocorreu mediante realização de entrevista coletiva semiestruturada, em março de 2019, com duração média de uma hora e trinta minutos. Realizou-se análise de conteúdo pela técnica do Discurso do Sujeito Coletivo. Resultados os discursos dos profissionais revelaram incertezas relacionadas à prevenção e ao tratamento da Infecção Latente por Tuberculose, ao "medo de errar" e formas inadequadas de uso da Isoniazida 300 mg, ao poder da decisão sobre o tratamento da Infecção Latente por Tuberculose, às dificuldades da integração entre os serviços e à organização de fluxos assistenciais. Conclusão embora a ênfase no discurso dos profissionais considere aspectos objetivos no manejo da Infecção Latente por Tuberculose, foram identificadas, dentre outras, manifestações subjetivas relacionadas à necessidade de trabalhar os receios que afetam a decisão sobre o tratamento e os possíveis erros de medicação, e de pensar esse processo de forma colaborativa, que considere autonomia no agir, tanto dos profissionais quanto da pessoa com Infecção Latente por Tuberculose.

Brazilian guidelines for the treatment of outpatients with suspected or confirmed COVID-19. A joint guideline of the Brazilian Association of Emergency Medicine (ABRAMEDE), Brazilian Medical Association (AMB), Brazilian Society of Angiology and Vascular Surgery (SBACV), Brazilian Society of Geriatrics and Gerontology (SBGG), Brazilian Society of Infectious Diseases (SBI), Brazilian Society of Family and Community Medicine (SBFMC), and Brazilian Thoracic Society (SBPT)

ABSTRACT Background Several therapies have been used or proposed for the treatment of COVID-19, although their effectiveness and safety have not been properly evaluated. The purpose of this document is to provide recommendations to support decisions about the drug treatment of outpatients with COVID-19 in Brazil. Methods A panel consisting of experts from different clinical fields, representatives of the Brazilian Ministry of Health, and methodologists (37 members in total) was responsible for preparing these guidelines. A rapid guideline development method was used, based on the adoption and/or adaptation of recommendations from existing international guidelines combined with additional structured searches for primary studies and new recommendations whenever necessary (GRADE-ADOLOPMENT). The rating of quality of evidence and the drafting of recommendations followed the GRADE method. Results Ten technologies were evaluated, and 10 recommendations were prepared. Recommendations were made against the use of anticoagulants, azithromycin, budesonide, colchicine, corticosteroids, hydroxychloroquine/chloroquine alone or combined with azithromycin, ivermectin, nitazoxanide, and convalescent plasma. It was not possible to make a recommendation regarding the use of monoclonal antibodies in outpatients, as their benefit is uncertain and their cost is high, with limitations of availability and implementation. Conclusion To date, few therapies have demonstrated effectiveness in the treatment of outpatients with COVID-19. Recommendations are restricted to what should not be used, in order to provide the best treatment according to the principles of evidence-based medicine and to promote resource savings by aboiding ineffective treatments.

Efectos del tratamiento con plasma de convaleciente con COVID-19 Revisión sistemática y metaanálisis / Effects of convalescent plasma treatment in patients with COVID-19: systematic review and meta-analysis

INTRODUCCIÓN: Se ha sugerido que el tratamiento con plasma de convaleciente en la enfermedad por coronavirus (COVID-19) mejora la evolución clínica en los casos moderados a graves. Este estudio fue diseñado para evaluar los efectos de este tratamiento en comparación con el tratamiento estándar o placebo en la mortalidad, el ingreso a asistencia ventilatoria mecánica y otros desenlaces críticos en personas hospitalizados con COVID-19 moderada a grave. MÉTODOS: Se siguieron los lineamientos PRISMA para la realización de una revisión sistemática. Se realizó una búsqueda sistemática en la plataforma L·OVE (Living OVerview of Evidence) de COVID-19 hasta el 15 de enero de 2021. Se incluyeron ensayos clínicos en los cuales se estudiaron personas con COVID-19 moderada, grave o crítica. La certeza de la evidencia se analizó mediante el enfoque de evaluación, desarrollo y evaluación de recomendaciones (GRADE, por su sigla en inglés). RESULTADOS: Se identificaron 10 ensayos controlados aleatorizados que incluyeron 11 854 pacientes, en los que se comparó el tratamiento con plasma de convaleciente y las medidas estándares de cuidado o placebo en pacientes con COVID-19. Estos no mostraron diferencias significativas sobre la mortalidad (riesgo relativo: 1,02; intervalo de confianza del 95%: 0,94-1,12). Podría producir un aumento marginal en el ingreso a ventilación mecánica y de los eventos adversos graves. DISCUSION: La evidencia actual muestra que el uso de plasma de convaleciente no tiene efecto en desenlaces críticos en pacientes con COVID-19 moderada o grave.

INTRODUCTION: It has been suggested that treatment with convalescent plasma in coronavirus disease (COVID-19) improves the clinical course in moderate to severe cases. This study was designed to evaluate the effects of this treatment compared to standard treatment or placebo on mortality, admission to mechanical ventilation, and other critical outcomes in people hospitalized with moderate to severe COVID-19. METHODS: The PRISMA guidelines were followed to carry out a systematic review. A systematic search was carried out on the L·OVE (Living OVerview of Evidence) platform for COVID-19 until January 15, 2021. Clinical trials were included in which people with moderate, severe or critical COVID-19 were studied. The certainty of the evidence was analyzed using the recommendation evaluation, development and evaluation (GRADE) approach. RESULTS: We identified 10 randomized controlled trials involving 11 854 patients in which convalescent plasma treatment and standard measures of care or placebo were compared in patients with COVID-19. These did not show significant differences on mortality (relative risk: 1.02; 95% confidence interval: 0.94-1.12). It could produce a marginal increase in admission to mechanical ventilation and serious adverse events. DISCUSSION: Current evidence shows that the use of convalescent plasma has no effect on critical outcomes in patients with moderate or severe COVID-19

Essential Oil from Citrus aurantium Alleviates Anxiety of Patients Undergoing Coronary Angiography: A Single-Blind, Randomized Controlled Trial / 中国结合医学杂志

OBJECTIVE@#To determine the effectiveness and safety of essential oil from Citrus aurantium on anxiety in patients undergoing coronary angiography.@*METHODS@#A single-blind, randomized controlled trial was conducted in 80 patients experiencing coronary angiography in Imam Ali Hospital in Kermanshah, Iran from April to November in 2016. All patients were randomly divided into intervention and control groups by a random number table, 40 cases in each group. The patients in the intervention group inhaled Citrus aurantium essential oil for 15-20 min about 60 min before angiography. Following the same procedure, distilled water was used instead of Citrus aurantium in the control group. Spielbergers State-Trait Anxiety Inventory (STAI) was filled in and vital signs including systolic blood pressure (SBP), diastolic blood pressure (DBP), respiratory and pulse rate were recorded before and 20 min after the intervention. Adverse reactions after intervention were observed.@*RESULTS@#In the intervention group, the mean scores of STAI, SBP, DBP, respiratory and pulse rate were 53.30 ± 10.13, 134.82 ± 11.75 mm Hg, 84.49 ± 6.99 mm Hg, 17.87 ± 1.73 times/min, and 76.48 ± 12.55 beats/min at baseline and significantly decreased to 42.37 ± 10.15, 124.49 ± 10.48 mm Hg, 79.23 ± 6.62 mm Hg, 14.54 ± 1.43 times/min, and 70.03 ± 13.66 beats/min respectively 20 min after intervention (all P0.05). All subjects reported no adverse reactions.@*CONCLUSION@#Inhalation of the essential oil from Citrus aurantium was effective in reducing anxiety and stress levels in patients undergoing coronary angiography.@*TRIAL REGISTRATION@#IRCT2016040816797N2 (retrospectively registered on 21 April 2016, https://en.irct.ir/trial/15600 ).

Drug treatment of laryngeal granuloma after hypothermic plasma radiofrequency surgery for early glottic carcinoma / 中国医师进修杂志

Objective:to investigate the efficacy of drugs in the treatment of laryngeal granuloma after hypothermic plasma radiofrequency surgery in early glottic carcinoma.Methods:Thirty-two cases of laryngeal granulomacoming from 289 patients with early glottic carcinoma treated by plasma radiofrequency surgery under endoscope-supported laryngoscopefrom January 2011 to January 2021 in Dalian Municipal Central Hospital were enrolled. All patients were given oral treatment of zinc gluconate tablets (70 grams per tablet, containing 10 grams of zinc). The usage was 3 tablets each time, twice a day. If the granulation was located in the vocal cord, 20 mg of esomeprazolec was added twice a day, and taken orally on an empty stomach. The total course of treatment was 6-12 weeks.Results:Follow-up and reexamination of electronic laryngoscope showed that the granulation of all patients began to become smaller after 3 weeks of drug treatment and gradually disappeared after 6-12 weeks. After the granulation disappeared, the drug was stopped, and there was no recurrence.Two patients developed nausea and epigastric discomfort after oral administration of zinc gluconate tablets for 3 weeks, and the discomfort disappeared after reducing the dose.Conclusions:Oral administration of zinc gluconate tablets alone or in combination with esomeprazoleis an effective, safe and low recurrence method for laryngeal granuloma after hypothermic plasma radiofrequency ablation in early glottic carcinoma.

Drug treatment of neonatal persistent pulmonary hypertension / 中国小儿急救医学

Neonatal persistent pulmonary hypertension refers to the continuous increase of pulmonary artery pressure, right heart pressure, right-to-left shunt at foramen ovale and ductus arteriosus level, severe hypoxemia and even respiratory failure after birth.At present, the drug treatments of neonatal persistent pulmonary hypertension include inhaling nitric oxide, sildenafil, milrinone, endothelin receptor antagonists bosentan, prostaglandins and their analogs.This review briefly summarized the progress on the treatment of neonatal persistent pulmonary hypertension.

Safety protocol on medication prescription, use and administration: mapping of nursing interventions / Protocolo de seguridad para la prescripción, el uso y la administración de medicamentos: mapeo de intervenciones de enfermería / Protocolo de segurança na prescrição, uso e administração de medicamentos: mapeamento de intervenções de enfermagem

ABSTRACT Objective: to analyze the correspondence between actions contemplated in the safety protocol on medication prescription, use and administration of the Ministry of Health with interventions of the Nursing Interventions Classification, by means of cross-mapping. Method: a descriptive study developed in four stages: extraction of the protocol's Nursing actions; identification of the interventions of the Nursing Interventions Classification; cross-mapping; and cross-mapping validation by experts. Results: 61 actions of the protocol and 32 interventions of the Nursing Interventions Classification were identified. After two rounds of mapping analysis by the experts, correspondence was identified between 53 actions and seven interventions. The interventions that presented the highest correspondence were the following: Medication Administration, Medication Management and Medication Prescription. Of the 53 mapped actions of the protocol, 56,6% were considered more detailed and specific than the activities of the interventions, 20,8% were classified as similar in meaning, 17,0% as broader and general, and 5,7% were only mapped with the title and definition of the intervention. Conclusion: the mapped actions of the protocol were considered more detailed and specific in relation to the activities of the interventions of the Nursing Interventions Classification. The unmapped interventions can contribute to elaborating operational protocols that expand the Nursing actions related to the mitigation of medication errors.

RESUMEN Objetivo: analizar la correspondencia entre las acciones contempladas en el protocolo de seguridad para la prescripción, el uso y la administración de medicamentos del Ministerio de la Salud y las intervenciones de la Clasificación de Intervenciones de Enfermería, por medio de la técnica de mapo cruzado. Método: estudio descriptivo desarrollado en cuatro etapas: extracción de las acciones de Enfermería del protocolo; identificación de las intervenciones de la Clasificación de Intervenciones de Enfermería; mapeo cruzado; y validación del mapeo cruzado a cargo de expertos. Resultados: se identificaron 61 acciones del protocolo y 32 intervenciones de la Clasificación de Intervenciones de Enfermería. Después de dos rondas de análisis del mapo a cargo de los expertos, se identificó correspondencia entre 53 acciones y siete intervenciones. Las intervenciones que presentaron mayor correspondencia fueron las siguientes: administración de medicamentos, control de medicamentos y prescripción de medicamentos. De las 53 acciones del protocolo mapeadas, se consideró que el 56,6% eran más detalladas y específicas que las actividades de las intervenciones, el 20,8% fueron clasificadas como similares en relación al significado, el 17,0% como más amplias y generales y el 5,7% se mapearon solamente con el título y la definición de la intervención. Conclusión: se consideró que las acciones del protocolo mapeadas eran más detalladas y específicas en relación con las actividades de las intervenciones de la Clasificación de Intervenciones de Enfermería. Las intervenciones no mapeadas pueden ser útiles para elaborar protocolos operativos que amplíen las acciones de Enfermería relacionadas a la mitigación de errores de medicación.

RESUMO Objetivo: analisar a correspondência entre ações contempladas no protocolo de segurança na prescrição, uso e administração de medicamentos do Ministério da Saúde com intervenções da Classificação de Intervenções de Enfermagem, por meio do mapeamento cruzado. Método: estudo descritivo desenvolvido em quatro etapas: extração das ações de enfermagem do protocolo; identificação das intervenções da Classificação de Intervenções de Enfermagem; mapeamento cruzado; e validação do mapeamento cruzado por peritos. Resultados: foram identificadas 61 ações do protocolo e 32 intervenções da Classificação de Intervenções de Enfermagem. Após duas rodadas de análise do mapeamento pelos peritos, identificou-se correspondência de 53 ações com sete intervenções. As intervenções que apresentaram maior correspondência foram: administração de medicamentos, controle de medicamentos e prescrição de medicamentos. Das 53 ações do protocolo mapeadas, 56,6% foram consideradas mais detalhadas e específicas do que as atividades das intervenções, 20,8% foram classificadas como similares em significado, 17,0% como mais amplas e gerais e 5,7% foram mapeadas apenas com o título e definição da intervenção. Conclusão: as ações do protocolo mapeadas foram consideradas mais detalhadas e específicas em relação às atividades das intervenções da Classificação de Intervenções de Enfermagem. As intervenções não mapeadas podem contribuir para a construção de protocolos operacionais que ampliem as ações de enfermagem relacionadas à mitigação de erros de medicação.

Impacto da pandemia da COVID-19 sobre o tratamento medicamentoso dos pacientes com doença arterial periférica: um estudo observacional transversal / Impact of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease: an observational cross-sectional study

Resumo Contexto A pandemia do Coronavírus 2019 (COVID-19) tem afetado negativamente o comportamento da população. Nesse contexto, o impacto da pandemia da COVID-19 no tratamento medicamentoso dos pacientes com doença arterial periférica (DAP) e claudicação intermitente (CI) permanece obscuro. Objetivos Analisar o impacto da pandemia da COVID-19 no tratamento medicamentoso dos pacientes com DAP e CI. Métodos Neste estudo observacional transversal, 136 pacientes com DAP e CI, recrutados do nosso banco de dados, responderam por telefone um questionário envolvendo as seguintes questões: a) cuidados com a COVID-19; b) saúde global; c) tratamento das doenças. Posteriormente, os pacientes foram divididos em dois grupos, de acordo com a dificuldade para a aquisição dos medicamentos (DAM: dificuldade e SDAM: sem dificuldade), para a comparação da saúde global entre os dois grupos. Resultados Dezessete porcento dos pacientes reportaram dificuldades para a aquisição dos medicamentos durante a pandemia. Uma maior prevalência desses pacientes reportou estar mais triste (56,5% versus 24,8%, p < 0,01) e com mais dificuldades para dormir (56,5% versus 24,8%, p < 0,01) em relação aos pacientes do grupo SDAM. Os grupos não apresentaram diferenças para o declínio na capacidade de caminhada, ansiedade, estresse e depressão (p > 0,05). Conclusões Uma maior prevalência de pacientes do grupo DAM reportou estar mais triste e com mais dificuldade para dormir em comparação ao grupo SDAM durante a pandemia da COVID-19.

Abstract Background The Coronavirus 2019 (COVID-19) pandemic has had a negative impact on the population's behavior. In this context, the effect of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease (PAD) and intermittent claudication (IC) remains unclear. Objectives To analyze the impact of the COVID-19 pandemic on drug treatment of patients with PAD and IC. Methods In this cross-sectional, observational study, 136 patients with PAD and IC were recruited from our database and answered a questionnaire by telephone involving the following questions: a) precautions related to COVID-19; b) general health status; and c) treatment of diseases. Subsequently, patients were divided into two groups according to difficulty in obtaining their drugs (DOD: difficulty obtaining drugs, or NDOD: no difficulty obtaining drugs) and overall health was compared between groups. Results Seventeen percent of patients reported difficulties with obtaining drugs during the pandemic. A higher proportion of these patients reported being sadder (56.5% vs. 24.8%, P < 0.01) and having more difficulty sleeping (56.5% vs. 24.8%, P < 0.01) than of the patients in the NDOD group (P <0.01). The groups did not differ in terms of impairment of walking capability, anxiety, stress, or depression (P> 0.05). Conclusions A higher proportion of patients in the DOD group reported being sadder and having greater difficulty sleeping compared to the NDOD group during the COVID-19 pandemic.

Efectividad del tratamiento acupuntural en las urgencias hipertensivas durante el preoperatorio de cirugías menores / Effectiveness of Acupuncture against Hypertensive Emergencies during the Preoperative of Minor Surgeries

Introducción: Las urgencias hipertensivas constituyen una de las complicaciones agudas más frecuentes de la hipertensión arterial y es causa de muerte prematura entre adultos. Muchas publicaciones abogan por el uso de la Medicina Tradicional y Natural como método terapéutico eficaz e inocuo en su manejo. Objetivo: Evaluar la efectividad del tratamiento acupuntural en las urgencias hipertensivas durante el preoperatorio en los pacientes que serán sometidos a intervenciones quirúrgicas ambulatorias menores en el Hospital Clínico Quirúrgico Dr. Juan Bruno Zayas Alfonso, de enero a octubre de 2019. Métodos: Se efectuó un estudio de intervención terapéutica. El universo estuvo constituido por 150 pacientes hipertensos que fueron asignados aleatoriamente a un grupo estudio que recibió tratamiento con acupuntura y un grupo control que recibió tratamiento medicamentoso. A todos se les realizó diagnóstico occidental y oriental. Ambos grupos estuvieron conformados por 75 pacientes. Resultados: Predominó el grupo de edades de 45 a 54 años en ambos grupos, un mayor número de mujeres enfermas. El síntoma que más afectó al total de los pacientes fue la cefalea y hubo superioridad del diagnóstico síndrome hiperactividad de fuego de hígado. El 74 por ciento de los pacientes a los que se les aplicó acupuntura mejoraron y un 66 por ciento lo lograron en el grupo control. Conclusiones: El tratamiento acupuntural resultó ser efectivo en los pacientes con urgencias hipertensivas durante el preoperatorio para las intervenciones quirúrgicas ambulatorios menores(AU)

Introduction: Hypertensive emergencies are one of the most frequent acute complications of arterial hypertension and the cause of premature death among adults. Many publications advocate the use of traditional and natural medicine as an effective and safe therapeutic method for its management. Objective: To assess the effectiveness of acupuncture against hypertensive emergencies during the preoperative period in patients who will undergo minor outpatient surgical interventions at Dr. Juan Bruno Zayas Alfonso Clinical-Surgical Hospital, from January to October 2019. Methods: A therapeutic intervention study was carried out. The population consisted of 150 hypertensive patients who were randomly assigned to either a study group that received acupuncture or a control group that received drug treatment, all of whom underwent Western and Eastern diagnoses. Both groups consisted of 75 patients. Results: The age set 45-54 years predominated in both groups, together with a greater number of sick women. The symptom that most affected all the patients was headache and there was superiority of the diagnosis of Liver-fire hyperactivity syndrome. 74 percent of the patients who received acupuncture improved, while 66 percent achieved it as part of the control group. Conclusions: Acupuncture turned out to be effective in patients with hypertensive emergencies during the preoperative period for minor outpatient surgeries(AU)